Trades on 4 secondary markets

Freenome

Freenome is an early cancer detection company founded in 2014 that develops blood-based screening tests to catch cancer in its earliest, most treatable stages. It combines multiomics laboratory science with artificial intelligence and machine learning to read multiple biological signals from a singl

emerging 15.0 / 100 0 APIs View provider profile →

Company Healthcare Cancer Detection Diagnostics Life Sciences Artificial Intelligence

Freenome is an API provider whose private shares are listed on 4 secondary markets: Forge Global, Hiive, EquityZen, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → H Hiive View listing → EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.